What one share of Sana Biotechnology holds
We were founded on the belief that engineered cells will be one of the most important transformations in medicine over the next several decades. The burden of diseases that can be addressed at their root cause through engineered cells is significant.
Sana Biotechnology’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$0.76 |
|---|---|
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$0.49 |
| Cash and investments | $0.54 |
| Book value | $0.52 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | — | −$26.67 | $5.33 | −$22.77 | — | −$29.07 |
| 2020 | — | −$21.92 | $1.83 | −$12.44 | — | −$26.05 |
| 2021 | — | −$2.14 | $0.18 | −$1.69 | — | $3.94 |
| 2022 | — | −$1.43 | $0.11 | −$1.65 | — | $2.61 |
| 2023 | — | −$1.46 | $0.10 | −$1.41 | — | $1.45 |
| 2024 | — | −$1.16 | $0.14 | −$1.11 | — | $1.12 |
| 2025 | — | −$0.96 | $0.00 | −$0.57 | — | $0.60 |
Common questions about Sana Biotechnology
How much does one share of Sana Biotechnology earn?
Over the last 12 months, Sana Biotechnology lost $0.76 for each share.
Does Sana Biotechnology pay a dividend?
Sana Biotechnology didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Sana Biotechnology’s book value per share?
Sana Biotechnology’s book value is $0.52 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Sana Biotechnology have?
Each share of Sana Biotechnology has $0.54 of cash and investments, as of June 30, 2026.
What is Sana Biotechnology’s free cash flow per share?
−$0.49 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Sana Biotechnology bought back shares?
Sana Biotechnology’s share count rose about 5065% from 2019 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.